Concepedia

Publication | Open Access

Skeletal Muscle Loss during Tyrosine Kinase Inhibitor Treatment for Advanced Hepatocellular Carcinoma Patients

DOIFull Paper Access

43

Citations

21

References

2019

Year

Shinsuke Uchikawa, Tomokazu Kawaoka, Maiko Namba, Kenichiro Kodama, Kazuki Ohya, Kei Morio, Takashi Nakahara, Eisuke Murakami, Masataka Tsuge, Akira Hiramatsu,
Liver Cancer

Abstract

This report demonstrated that patients receiving TKI treatment experienced a significant loss of skeletal muscle mass regardless of disease progression, hepatic reserve, or which TKI (sorafenib or lenvatinib) they received.

References

YearCitations

Page 1